In this article, the authors discuss their research using non-ribosome targeting tobramycin-based adjuvants to overcome the intrinsic resistance observed in bacteria, Pseudomonas aeruginosa.
Browsing: Clinical > Antimicrobial Resistance
A new survey has reported that nearly half of parents have kept leftover antibiotics, and of these 73% have shared the drugs with other family and non-family.
In recent years, researchers have discovered the potential of CRISPR as an antimicrobial. In this blog post we explain the recent advances made in this field and the different approaches by which CRISPR can be used as a new weapon in the battle against antimicrobial resistance.
Gauri Godbole, from Public Health England, gives us an overview of recent advances and updates in the field of gastrointestinal infections – from the impact of the microbiome to the growing threat of antimicrobial resistance.
A Phase II trial has demonstrated that a new investigational antibiotic, cefiderocol, is as effective as the current standard-of-care for treating complicated UTIs caused by multi-drug resistant bacteria.
The UK’s Health & Social Care Select Committee has concluded that antimicrobial resistance should be established as a ‘top five policy priority’ for the UK Government.
In this interview we speak to Amy Mathers about her research on the role of hospital plumbing in the evolution and exchange of genes of drug resistance.
Scientists, led by the National University of Singapore and the University of Glasgow, have used the term ‘lateral transduction’ to describe a novel, dangerously-potent mechanism of bacteriophage-induced genetic transduction.
In this interview, we speak to to Keith Kaye, Principle Investigator of the RESTORE-1 trial assessing relebactam in combination with imipenem (IMI/REL), about the trial’s results and the implications these have for clinicians in ‘real world’ settings.
Nearly half of prescriptions for antibiotics were written without an infection-related diagnosis, according to a study of 509,534 prescriptions reported at IDWeek today.